MARKET

CAPR

CAPR

Capricor Therapeutics Inc
NASDAQ
24.72
+1.69
+7.34%
After Hours: 25.20 +0.48 +1.94% 19:59 02/06 EST
OPEN
23.36
PREV CLOSE
23.03
HIGH
25.21
LOW
23.23
VOLUME
1.13M
TURNOVER
--
52 WEEK HIGH
40.37
52 WEEK LOW
4.300
MARKET CAP
1.28B
P/E (TTM)
-13.7448
1D
5D
1M
3M
1Y
5Y
1D
Capricor Therapeutics Unveils Investor Presentation Highlighting Duchenne Program and Exosome Platform
Reuters · 3d ago
Capricor Therapeutics stellt neue Pipeline-Strategien und Fortschritte bei Duchenne-Muskeldystrophie-Therapien vor
Reuters · 3d ago
Weekly Report: what happened at CAPR last week (0126-0130)?
Weekly Report · 6d ago
Analysts Are Bullish on These Healthcare Stocks: Capricor Therapeutics (CAPR), Tvardi Therapeutics (TVRD)
TipRanks · 01/29 13:40
Weekly Report: what happened at CAPR last week (0119-0123)?
Weekly Report · 01/26 09:37
BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Seagate, Western Digital
Reuters · 01/20 18:44
BUZZ-U.S. STOCKS ON THE MOVE -Alignment Healthcare, Capricor Therapeutics, silver miners
Reuters · 01/20 15:44
BUZZ-Capricor rises after FDA asks for more data but no new trials for Duchenne therapy
Reuters · 01/20 14:29
More
About CAPR
Capricor Therapeutics, Inc. is a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases. The Company's program is focused on the development and commercialization of a cell therapy technology comprised of cardiosphere-derived cells (CDCs) for the treatment of Duchenne muscular dystrophy (DMD). Its lead product candidate deramiocel (also referred to as CAP-1002), is an allogeneic cardiac-derived cell therapy. CAP-1002 is advancing through Phase III clinical development for the treatment of Duchenne muscular dystrophy (DMD). CAP-1002 demonstrates immunomodulatory, antifibrotic, and regenerative actions specifically tailored for dystrophinopathies and heart disease. It leverages its exosome technology, using its StealthX platform in preclinical development focused on the areas of vaccinology, targeted delivery of oligonucleotides, proteins, and small molecule therapeutics.

Webull offers Capricor Therapeutics Inc stock information, including NASDAQ: CAPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAPR stock methods without spending real money on the virtual paper trading platform.